Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Moritz N Wente

Showing results (51-60 of 66) with videos related to

Pageof 7
Sort By:
Thyroid : Official Journal of the American Thyroid Association|December 11, 2014
Survival after renal cell carcinoma metastasis to the thyroid: single center experience and systematic review of the literatureUlrich Beutner, Christine Leowardi, Ulrich Bork, et al.
BMC Cancer|December 1, 2009
An open label randomized multicentre phase IIIb trial comparing parenteral substitution versus best supportive nutritional care in subjects with pancreatic adenocarcinoma receiving 5-FU plus oxaliplatin as 2nd or higher line chemotherapy regarding clinical benefit - PANUSCOAngela Märten, Moritz N Wente, Jennifer Ose, et al.
International Journal of Oncology|July 19, 2008
Expression and potential function of the CXC chemokine CXCL16 in pancreatic ductal adenocarcinomaMoritz N Wente, Matthias M Gaida, Christine Mayer, et al.
Pathology Oncology Research : POR|September 13, 2011
Expression of galectin-3 in pancreatic ductal adenocarcinomaMatthias M Gaida, Sylvia T Bach, Frank Günther, et al.
Patient Safety in Surgery|August 10, 2012
Renal tumors and second primary pancreatic tumors: a relationship with clinical impact?Sascha A Müller, Sascha Pahernik, Ulf Hinz, et al.
Langenbeck'S Archives of Surgery|March 1, 2008
R2 resection in pancreatic cancer--does it make sense?Jörg Köninger, Moritz N Wente, Beat P Müller-Stich, et al.
Cancer Letters|February 7, 2006
Blockade of the chemokine receptor CXCR2 inhibits pancreatic cancer cell-induced angiogenesisMoritz N Wente, Michael P Keane, Marie D Burdick, et al.
Pancreas|July 19, 2005
Prostate stem cell antigen is a putative target for immunotherapy in pancreatic cancerMoritz N Wente, Anjali Jain, Evelyn Kono, et al.
BMC Surgery|July 18, 2015
The TICAP-Study (titanium clips for appendicular stump closure): A prospective multicentre observational study on appendicular stump closure with an innovative titanium clipAlexander Rickert, Colin M Krüger, Norbert Runkel, et al.
Annals of Surgical Oncology|October 28, 2005
Malignant vascular tumors: clinical presentation, surgical therapy, and long-term prognosisChristine Leowardi, Ulf Hinz, Yura Hormann, et al.
Pageof 7

Showing results (51-60 of 66) with videos related to

Sort By:
Pageof 7
Thyroid : Official Journal of the American Thyroid Association|December 11, 2014
Survival after renal cell carcinoma metastasis to the thyroid: single center experience and systematic review of the literatureUlrich Beutner, Christine Leowardi, Ulrich Bork, et al.
BMC Cancer|December 1, 2009
An open label randomized multicentre phase IIIb trial comparing parenteral substitution versus best supportive nutritional care in subjects with pancreatic adenocarcinoma receiving 5-FU plus oxaliplatin as 2nd or higher line chemotherapy regarding clinical benefit - PANUSCOAngela Märten, Moritz N Wente, Jennifer Ose, et al.
International Journal of Oncology|July 19, 2008
Expression and potential function of the CXC chemokine CXCL16 in pancreatic ductal adenocarcinomaMoritz N Wente, Matthias M Gaida, Christine Mayer, et al.
Pathology Oncology Research : POR|September 13, 2011
Expression of galectin-3 in pancreatic ductal adenocarcinomaMatthias M Gaida, Sylvia T Bach, Frank Günther, et al.
Patient Safety in Surgery|August 10, 2012
Renal tumors and second primary pancreatic tumors: a relationship with clinical impact?Sascha A Müller, Sascha Pahernik, Ulf Hinz, et al.
Langenbeck'S Archives of Surgery|March 1, 2008
R2 resection in pancreatic cancer--does it make sense?Jörg Köninger, Moritz N Wente, Beat P Müller-Stich, et al.
Cancer Letters|February 7, 2006
Blockade of the chemokine receptor CXCR2 inhibits pancreatic cancer cell-induced angiogenesisMoritz N Wente, Michael P Keane, Marie D Burdick, et al.
Pancreas|July 19, 2005
Prostate stem cell antigen is a putative target for immunotherapy in pancreatic cancerMoritz N Wente, Anjali Jain, Evelyn Kono, et al.
BMC Surgery|July 18, 2015
The TICAP-Study (titanium clips for appendicular stump closure): A prospective multicentre observational study on appendicular stump closure with an innovative titanium clipAlexander Rickert, Colin M Krüger, Norbert Runkel, et al.
Annals of Surgical Oncology|October 28, 2005
Malignant vascular tumors: clinical presentation, surgical therapy, and long-term prognosisChristine Leowardi, Ulf Hinz, Yura Hormann, et al.
Pageof 7